You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Denosumab

Showing 1 - 25 of 322
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcopenia, Osteoporosis, Denosumab Trial in Wuhan (Denosumab Injection, Normal saline injection (1.0ml/ branch))

Not yet recruiting
  • Sarcopenia
  • +2 more
  • Denosumab Injection
  • Normal saline injection (1.0ml/ branch)
  • Wuhan, Hubei, China
    Union Hospital Tongji Medical College Huazhong University of Sci
Nov 23, 2023

Denosumab Allergy, Zoledronic Acid Allergy Trial in Shenzhen (Denosumab Injection, Zoledronate)

Completed
  • Denosumab Allergy
  • Zoledronic Acid Allergy
  • Shenzhen, Guangdong, China
    ShenzhenPH
Jan 15, 2023

Denosumab Allergy Trial in Shenzhen (Denosumab, Alendronate, Placebo)

Recruiting
  • Denosumab Allergy
  • Denosumab
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen People's Hospital
Dec 21, 2022

Osteoporosis in Postmenopausal Women Trial (Eldecalcitol, Native Vitamin D, Denosumab)

Not yet recruiting
  • Osteoporosis in Postmenopausal Women
  • (no location specified)
Jun 1, 2023

Osteoporosis, Spine Fusion, Denosumab Allergy Trial in Shenzhen (Denosumab, Placebo)

Completed
  • Osteopenia
  • +2 more
  • Denosumab
  • Placebo
  • Shenzhen, Guangdong, China
    ShenzhenPH
Jan 15, 2023

Osteopenia, Lumbar Spondylolisthesis Trial in Shenzhen (Denosumab 60 MG/ML, Zoledronate)

Recruiting
  • Osteopenia
  • Lumbar Spondylolisthesis
  • Shenzhen, Guangdong, China
    ShenzhenPH
Dec 29, 2022

Fibrous Dysplasia, McCune Albright Syndrome Trial in Leiden (Denosumab 120 Mg/1.7 Ml Inj, Placebo)

Recruiting
  • Fibrous Dysplasia
  • McCune Albright Syndrome
  • Denosumab 120 Mg/1.7 Ml Inj
  • Placebo
  • Leiden, Netherlands
    Leiden University Medical Center
Jul 20, 2023

Chronic Kidney Diseases, Fracture, Bone Density, Low Trial in Beijing (Denosumab, Non-denosumab)

Recruiting
  • Chronic Kidney Diseases
  • +3 more
  • Beijing, Beijing, China
    Nephrology Department of Beijing Jishuitan Hospital
Jan 20, 2023

Smoldering Multiple Myeloma Trial in Rochester (Denosumab)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Denosumab
  • Rochester, New York
    University of Rochester
Oct 3, 2022

Denosumab Safety Assessment in Multiple Observational Databases

Active, not recruiting
  • Osteoporosis
  • (no location specified)
Jan 13, 2023

Single or Repeat Zoledronate Versus Alendronate Following

Not yet recruiting
  • Osteoporosis, Postmenopausal
  • Zoledronate or Alendronate
  • Thessaloniki, Greece
    424 General Military Hospital
Jan 24, 2023

Osteoporosis, Postmenopausal Trial (Zoledronate, Placebo)

Not yet recruiting
  • Osteoporosis, Postmenopausal
  • (no location specified)
Dec 15, 2022

Adult Idiopathic Generalized Osteoporosis Trial in Omaha, New York (Denosumab)

Completed
Has Results
  • Adult Idiopathic Generalized Osteoporosis
  • Denosumab
  • Omaha, Nebraska
  • +1 more
Nov 15, 2022

Primary Hyperparathyroidism Trial in New York (Denosumab, Placebo)

Terminated
Has Results
  • Primary Hyperparathyroidism
  • Denosumab
  • Placebo
  • New York, New York
    Columbia University Medical Center
Oct 6, 2022

Osteoarthritis, Knee Trial (Denosumab 60 MG/ML Injectable Solution [Prolia], Placebo)

Not yet recruiting
  • Osteoarthritis, Knee
  • Denosumab 60 MG/ML Injectable Solution [Prolia]
  • Placebo
  • (no location specified)
Sep 28, 2022

Osteopenia, Osteoporosis Trial (Denosumab)

Completed
Has Results
  • Osteopenia
  • Osteoporosis
  • Denosumab
  • (no location specified)
Nov 4, 2022

Bone Metastases Trial (Denosumab, Zoledronic Acid)

Completed
Has Results
  • Bone Metastases
  • Denosumab
  • Zoledronic Acid
  • (no location specified)
Nov 4, 2022

Osteoporotic Vertebral Compression Fracture Trial in Shenzhen (Denosumab 60 mg/ml [Prolia], Placebo)

Completed
  • Osteoporotic Vertebral Compression Fracture
  • Denosumab 60 mg/ml [Prolia]
  • Placebo
  • Shenzhen, Guangdong, China
    ShenzhenPH
Aug 17, 2022

Osteoporosis, Postmenopausal Trial in Jaipur (Denosumab, Denosumab-Ref)

Recruiting
  • Osteoporosis, Postmenopausal
  • Jaipur, Rajasthan, India
    S. R. Kalla Memorial Gastro & General Hospital
Aug 16, 2022

Langerhans Cell Histiocytosis Trial in Athens (Denosumab 70 MG/ML [Xgeva])

Completed
  • Langerhans Cell Histiocytosis
  • Denosumab 70 MG/ML [Xgeva]
  • Athens, Attiki, Greece
    251 Hellenic AirForce & VA General Hospital, Dpt of Endocrinolog
Oct 1, 2022

Fibrous Dysplasia Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (denosumab)

Recruiting
  • Fibrous Dysplasia
  • denosumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 15, 2022

Alendronate inWeekly Effervescent Tablet Formulation Following

Recruiting
  • Postmenopausal Osteoporosis
  • Binosto 70Mg Effervescent Tablet
  • Athens, Attiki, Greece
    251 Hellenic Air Force & VA General Hospital
Nov 6, 2022

Hypovitaminosis D, Osteoporosis, Postmenopausal, Menopause Trial in Mexico City (Cholecalciferol)

Completed
  • Hypovitaminosis D
  • +2 more
  • Mexico City, Gustavo A. Madero, Mexico
    Patricia Loranca-Moreno
Jan 24, 2023

Ovarian Carcinoma Trial in Israel, United States (Denosumab, Salpingo-Oophorectomy)

Terminated
Has Results
  • Ovarian Carcinoma
  • Denosumab
  • Salpingo-Oophorectomy
  • Boston, Massachusetts
  • +5 more
May 23, 2022

Premenopausal Idiopathic Osteoporosis Trial in New York (Romosozumab Prefilled Syringe [Evenity], Denosumab 60 MG/ML Prefilled

Recruiting
  • Premenopausal Idiopathic Osteoporosis
  • Romosozumab Prefilled Syringe [Evenity]
  • Denosumab 60 MG/ML Prefilled Syringe [Prolia]
  • New York, New York
    Columbia University Irving Medical Center
Oct 5, 2022